TechHighPartialAccelerating
8.0
Anthropic, OpenAI flag recursive self-improvement risk as AI nears RSI threshold
Axios·US·1 day ago
TechSingle-sourceMedium
5.2
Anthropic Launches Biology Lab to Apply AI in Drug Discovery
Anthropic is establishing a biology lab to apply AI to protein design and hypothesis testing, signaling a strategic expansion into life sciences. The move could accelerate drug discovery but faces scientific and regulatory hurdles. It underscores Big Tech's growing role in biotech.
Score Breakdown
Mosaic Score5.2
Confidence0.5
Significance0.5
Source credibility0.5
Related signals
8 foundTechHighPartialAccelerating
7.2
AI Safety vs. Speed: Industry Split Deepens as Trump Pushes Accelerated Development
RzeczpospolitaLO·US · CN·3 days ago
MarketsNotableEmerging
5.5
Anthropic IPO valuation math: multiple paths to a higher price
Financial Times·US·2 days ago
TechNotableEmergingDeveloping
5.3
AI training dispute: Anthropic vs. OpenAI over human-like behavior risks
New York Times·US·2 days ago
TechNotableSingle-source
5.0
Anthropic Unveils Opus 5.5, Claims Top Safety Performance
NYT Tech·US·about 20 hours ago
TechNotableSingle-source
5.0
Anthropic Launches Claude Opus 5.5: Flagship Performance at 40% Lower Cost
Valor Econômico·US·about 20 hours ago
TechNotableSingle-source
4.8
Anthropic IPO valuation range spans $2T to $100T, FT analysis
Dagens IndustriLO·US·about 21 hours ago
TechNotableEmerging
4.8
Corteva spin-off Vylor and Rainbow Crops partner on AI-driven climate-resilient maize
La Nación (Argentina)LO·AR·2 days ago